US public health preparedness and response to highly pathogenic avian influenza A(H5N1) viruses

JAMA

2024-05-21

(Press-News.org) About The Study: Public health authorities in nearly all states and territories surveyed reported the ability to monitor and test persons exposed to highly pathogenic avian influenza (HPAI) A(H5N1) virus. However, jurisdictions varied in their capacity to monitor exposed persons, in recommendations for use of antivirals, and in potential use of H5N1 vaccines, if available, among first responders.

Corresponding Author: To contact the corresponding author, Noah Kojima, M.D., email nkojima@cdc.gov.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.10116)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10116?guestAccessKey=97235608-3017-4f2a-b30c-8486923bab25&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052124

END

ELSE PRESS RELEASES FROM THIS DATE:

DRI to host AWE+ wildfire summit

2024-05-21

Today, DRI, one of our nation’s leading applied environmental research institutes, together with its Foundation, announced a new global initiative with the first in a series of summits. The event will be held at Encore Las Vegas from August 21-23, 2024. The AWE+ initiative will promote an Adaptable World Environment of strong, resilient communities in a climate shifting world. AWE+ 2024 - Wildfire Recovery and Resilience: Working Across Silos to Drive Solutions - is a global call-to-action for communities ...

MD Anderson Research Highlights for May 21, 2024

2024-05-21

HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson offer insights into biomarkers that predict immunotherapy responses, a possible treatment strategy for patients with LKB1-deficient cancers, therapeutic targets to prevent acute myeloid leukemia (AML) progression ...

Polymer research aims to expand possibilities in sensor technology

2024-05-21

Sensors enable us to monitor changes in systems of all kinds. The materials at the heart of those sensors, of course, ultimately determine their end-use application. Devices made of silicon, for example, enable ultrafast processing in computers and phones, but they aren’t pliable enough for use in physiological monitoring. They also require a lot of energy to produce. Lehigh University professor Elsa Reichmanis, Carl Robert Anderson Chair in the Department of Chemical and Biomolecular Engineering, recently received a grant from the National ...

New therapeutic avenues in bone repair

2024-05-21

Birmingham researchers have shown PEPITEM, a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature bone loss, with distinct advantages over existing drugs. PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration) was first identified in 2015 by University of Birmingham researchers. The latest research, published today in Cell Reports Medicine, show for the first time that PEPITEM could be used as a novel and early clinical intervention to reverse the impact of age-related musculoskeletal diseases, with ...

Socioeconomic status transition throughout life and risk of dementia

2024-05-21

About The Study: This cohort study of Japanese older adults identified that upward and downward socioeconomic status transitions were associated with risk of dementia and the length of dementia-free periods over the lifespan. The results may be useful to understand the association between social mobility and healthy longevity. Corresponding Author: To contact the corresponding author, Hiroyasu Iso, Ph.D., email iso@pbhel.med.osaka-u.ac.jp. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.12303) Editor’s Note: Please see ...

Climbing the social ladder slows dementia, Japanese study reveals

2024-05-21

Osaka, Japan – Upward social mobility may ward off dementia, according to a new study. Dementia, a collective term for conditions marked by memory loss and diminished cognitive functioning, strains healthcare systems and devastates quality of life for patients and their families. Research thus far has found correlations between socioeconomic status (SES) – Parent’s asset, education level, income, and work status – and susceptibility to dementia, and SES changes throughout a person’s life, known as social mobility, seem to influence this risk; however, scientific ...

Researchers discover hidden step in dinosaur feather evolution

2024-05-21

Scientists discover ‘zoned development’ in dinosaur skin, with zones of reptile-style scales and zones of bird-like skin with feathers New dinosaur skin fossil found to be composed of silica – the same as glass Discovery sheds light on evolution from scales to feathers Palaeontologists at University College Cork (UCC) in Ireland have discovered that some feathered dinosaurs had scaly skin like reptiles today, thus shedding new light on the evolutionary transition from scales to feathers. The researchers studied a new specimen of the feathered dinosaur Psittacosaurus from the early Cretaceous ...

Studies reveal cell-by-cell changes caused when pig hearts and kidneys are transplanted into humans

2024-05-21

Surgical teams at NYU Langone Health performed the world’s first genetically modified pig kidney transplants into a human body in September and November 2021, and then transplanted two pig hearts in the summer of 2022. These procedures were done in patients declared dead based on neurologic criteria (decedents) and maintained on ventilators with the consent of their families. Demonstrating the field’s progress, NYU Langone in April 2024 transplanted a pig kidney into a living patient. Now two new analyses, one published online on May 17 in Nature Medicine and the other May ...

SRI earns FDA Orphan Drug Designation for pancreatic cancer

2024-05-21

SRI’s Targeted Antigen Loaded Liposomes (TALL) — a treatment that expands the benefits of immunotherapy such as check-point inhibitors — has been granted Orphan Drug Designation (ODD) for pancreatic ductal adenocarcinoma (PDAC) by the U.S. Federal Drug Administration (FDA). As a result, SRI’s future strategic partners can gain tax credits for qualified clinical trials and potentially receive market exclusivity for a period of seven years after the drug’s approval, among other benefits. “FDA's orphan drug designation brings worthy attention to the demonstrated impact of SRI's TALL biotherapeutic for pancreatic cancer,” said Kathlynn Brown, ...

A new gene-editing system tackles complex diseases

2024-05-21

The human genome consists of around 3 billion base pairs and humans are all 99.6% identical in their genetic makeup. That small 0.4% accounts for any difference between one person and another. Specific combinations of mutations in those base pairs hold important clues about the causes of complex health issues, including heart disease and neurodegenerative diseases like schizophrenia. Current methods to model or correct mutations in live cells are inefficient, especially when multiplexing — installing multiple point mutations simultaneously across the genome. Researchers from the University of California San Diego ...

The percentage of women who went without a Pap smear for cervical cancer screening increased following the COVID-19 pandemic, from 19% in 2019 to 26% in 2022

US public health preparedness and response to highly pathogenic avian influenza A(H5N1) viruses

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: